Insiders · CLDI

CLDI insider transactions

Calidi Biotherapeutics Inc. (CLDI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

CLDI insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Calidi Biotherapeutics Inc., latest first. Follow anyone to get their next filing.

• George PeoplesDirector, since July 2024
• Alan R. StewartDirector, since October 2023
• Scott LeftwichDirector, since September 2023+$250K
• James A SchoeneckDirector, since September 2023+$150K
• Santidrian Antonio FernandezChief Scientific Officer, since September 2023
• Andrew C. JacksonChief Financial Officer, since October 2023+$5,000
• Sanders Corazon (Corsee) D.Director, since June 2026
• Eric E PomaChief Executive Officer, since April 2025+$50K
• Allan CamaisaCEO and Chairman of the Board, Director, since September 2023-$17.4K
• Lincoln Alternative Strategies LLC10% owner, since August 2025
• Boris Radoslavov MinevInterim Chief Medical Officer, since September 2023
• Wendy Pizarro CampbellChief Admin. and Legal Officer, since September 2023
• David LaPreDirector, since January 2024
• Alfonso G ZuluetaDirector
• Thomas A. VecchiollaDirector
• Heehyoung LeeDirector, since September 2023
• Stephen ThesingOfficer, since September 2023
• David SansOfficer, since September 2023
• Tony T KalajianOfficer, since September 2023
• Amish PatelOfficer, since September 2023
• George K NgDirector, since September 2023
• First Light Acquisition Group, LLC10% owner
• Hudson Bay Capital Management LP10% owner, since October 2022
• Polar Asset Management Partners Inc.10% owner, since September 2022-$358K

Recent Form 3, 4, and 5 filings for CLDI

• 81d
  SEC Form 4 filed by Chief Financial Officer Jackson Andrew C.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 81d
  SEC Form 4 filed by Chief Scientific Officer Fernandez Santidrian Antonio

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 81d
  SEC Form 4 filed by Director Schoeneck James A

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 81d
  SEC Form 4 filed by Director Leftwich Scott

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 81d
  SEC Form 4 filed by Director Stewart Alan R.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 81d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 81d
  SEC Form 4 filed by Director Sanders Corazon (Corsee) D.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 81d
  SEC Form 4 filed by Chief Executive Officer Poma Eric E

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 132d
  SEC Form 3 filed by new insider Sanders Corazon (Corsee) D.

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 327d
  Director Camaisa Allan sold $1,237 worth of shares (850 units at $1.46) (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 429d
  SEC Form 4 filed by Chief Executive Officer Poma Eric E

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 429d
  SEC Form 4 filed by Chief Scientific Officer Fernandez Santidrian Antonio

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 429d
  SEC Form 4 filed by Chief Financial Officer Jackson Andrew C.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 438d
  New insider Lincoln Alternative Strategies Llc claimed ownership of 730,000 shares (SEC Form 3)

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 440d
  Chief Financial Officer Jackson Andrew C. bought $5,000 worth of shares (2,500 units at $2.00) (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 440d
  Chief Executive Officer Poma Eric E bought $50,000 worth of shares (25,000 units at $2.00) (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 440d
  Director Leftwich Scott bought $250,000 worth of shares (125,000 units at $2.00), increasing direct ownership by 2,212% to 130,650 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 440d
  Director Schoeneck James A bought $150,000 worth of shares (75,000 units at $2.00), increasing direct ownership by 6,614% to 76,134 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 481d
  SEC Form 4 filed by Director Leftwich Scott

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 481d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 481d
  SEC Form 4 filed by Director Schoeneck James A

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 481d
  SEC Form 4 filed by Director Stewart Alan R.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 562d
  SEC Form 4 filed by Chief Executive Officer Poma Eric E

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 562d
  SEC Form 3 filed by new insider Poma Eric E

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 674d
  Director Stewart Alan R. was granted 12,771 shares, increasing direct ownership by 79% to 28,976 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 674d
  Director Leftwich Scott was granted 11,684 shares, increasing direct ownership by 21% to 67,774 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 690d
  CEO and Chairman of the Board Camaisa Allan sold $16,200 worth of shares (10,000 units at $1.62), decreasing direct ownership by 13% to 66,712 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 754d
  SEC Form 4 filed by Director Stewart Alan R.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 754d
  SEC Form 4 filed by Director Leftwich Scott

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 754d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 754d
  SEC Form 4 filed by Director Schoeneck James A

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 769d
  CEO and Chairman of the Board Camaisa Allan was granted 70,155 shares (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 850d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 850d
  SEC Form 3 filed by new insider Peoples George

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 859d
  Director Leftwich Scott was granted 67,187 shares, increasing direct ownership by 14% to 560,873 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 859d
  Director Schoeneck James A was granted 79,687 shares, increasing direct ownership by 8% to 1,071,781 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 859d
  Director Stewart Alan R. was granted 73,437 shares, increasing direct ownership by 91% to 154,087 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 859d
  Director Leftwich Scott was granted 23,783 shares, increasing direct ownership by 5% to 493,686 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 859d
  Director Schoeneck James A was granted 28,207 shares, increasing direct ownership by 3% to 992,094 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 859d
  Director Stewart Alan R. was granted 25,995 shares, increasing direct ownership by 48% to 80,650 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 871d
  SEC Form 4 filed by Chief Financial Officer Jackson Andrew C.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 871d
  SEC Form 4 filed by CEO and Chairman of the Board Camaisa Allan

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 871d
  SEC Form 4 filed by Chief Admin. and Legal Officer Campbell Wendy Pizarro

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 871d
  SEC Form 4 filed by Interim Chief Medical Officer Minev Boris Radoslavov

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 886d
  Schoeneck James A exercised 548,000 shares at a strike of $0.20 (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 930d
  Schoeneck James A was granted 375,000 shares (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 971d
  SEC Form 3 filed by new insider Lapre David

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)